Prevention therapeutics of dementia
- PMID: 18631988
- DOI: 10.1016/j.jalz.2007.11.005
Prevention therapeutics of dementia
Abstract
In the absence of effective drugs for Alzheimer's disease (AD) and a validated roadmap or guideline for drug development, it is important to consider some of the limitations currently hampering AD drug development and some general principles for moving forward. This paper will address current barriers to developing drugs for AD, and offer new considerations for accelerating drug discovery, development, and clinical trials.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
